A Clinical Study of YL205 in Patients With Advanced Solid Tumors

NCT06459973 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: intravenous (IV) infusion

Sponsor

MediLink Therapeutics (Suzhou) Co., Ltd.